Urologix, Inc. has received FDA approval to market the Cooled ThermoCathtreatment catheter, which is designed for use in conjunction with the company'sTargis microwave generator, for the treatment of BPH. The product incorporatescatheter cooling technology designed to improve the heat exchange coupledwith improved catheter conformance to urethral tissue.
Jessica Feehan, NP-C, discusses the expanding role of APPs in urology, from clinical leadership and procedures to care coordination and treatment initiation.
Sam S. Chang, MD, MBA, discusses treatment selection after BCG failure, including bladder-sparing options, cystectomy considerations, and the need for sequencing data.
Justin B. Ziemba, MD, discusses clinical factors that help identify patients at increased risk for kidney stone recurrence and guide metabolic evaluation.
Adam Sharp, PhD, BM, MRCP, BSc, discusses preliminary safety and efficacy findings from a phase 1/2 study of gedatolisib plus darolutamide in patients with mCRPC.